Clinical Trial Details

Overview

Research Study Summary

Second Phase 3 Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of XXXXXX in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Purpose

A 12-week research study to test the safety and effectiveness of an investigational medication for the treatment of Irritable Bowel Syndrome with Constipation.

To Learn more

CW ID: 213917
Date Last Changed: March 31, 2016

Clinical Trial Snapshot

Phase
3
Gender
Both Male and Female
Age
18 to 85 Years
Overall Status
Recruiting
Duration
18 Weeks
Facility Type
Out-Patient
Compensation
Up to $450

Eligibility

Eligibility Criteria
  • Between 18 to 85 years old
  • Currently experiencing abdominal pain and constipation from IBS
  • Complete daily reports on your symptoms throughout the study
  • Be able to participate for approximately 18 weeks

Contact

Jennifer Wu, Clinical Research Coordinator
IMA Research
80-02 Kew Gardens Road, Suite 102
Kew Gardens, NY 11415
Phone: 866-879-2507 Ext. 711
Fax: 866-600-5303

View Map

Research Center Information:

IMA Research

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.